Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UNLOCKING LEGALITIES: Challenges And Surprises In The EU Medtech Reg Reform

This article was originally published in SRA

Executive Summary

The texts of the new EU medical device and IVD regulations have now been published in their likely final versions, save for the tweaking expected during the European Commission's legal review. Scrip Regulatory Affairs sister publication Clinica asked Erik Vollebregt, partner at Axon Lawyers, what the most significant challenges will be now for the whole of the medtech sector, and where the biggest surprises lie.

Advertisement

Related Content

EU TTIP Device Proposals Rely Heavily on Device Regulators Forum
Advertisement
UsernamePublicRestriction

Register

MT040827

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel